Asia-Pacific Osteoarthritis Therapeutics market was valued at $2,744.0 million in 2025 and is projected to reach $6,285.0 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026–2035). Expansion of local pharmaceutical manufacturing capacity in key Asia-Pacific markets such as China and India is strengthening drug availability, lowering treatment costs, and directly supporting growth in the osteoarthritis therapeutics market. According to the Ministry of Commerce and Industry, India’s pharmaceuticals industry reached approximately $57 billion in annual turnover in 2023.

Asia-Pacific High-Performance Liquid Chromatography (HPLC) market was valued at $1,471.3 million in 2025 and is projected to reach $2,357.6 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). The market is witnessing significant technological advancements that are expanding analytical capabilities and improving laboratory efficiency. Manufacturers are introducing ultra-high-pressure liquid chromatography (UHPLC) systems that deliver faster separations with higher resolution and lower solvent use compared with traditional HPLC platforms. Recent launches include next-generation detectors such as multi-wavelength UV, charged aerosol detectors, and interfaces compatible with mass spectrometry, enabling broader analyte detection and improved quantitative accuracy in complex sample matrices.

US HPLC market was valued at $1,848.4 million in 2025 and is expected to reach $2,763.9 million by 2035, registering a CAGR of 4.2% over the forecast period from 2026 to 2035. The rapid expansion of biologics and complex therapeutic development in the US is a key driver of HPLC demand, particularly for advanced analytical characterization and quality control applications. In 2024, the US Food and Drug Administration approved 50 new therapies, including small molecules and biologics, marking one of the highest annual totals of novel drug approvals on record. 

North America Osteoarthritis Therapeutics market was valued at $4,256.0 million in 2025 and is projected to reach $9,551.3 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026–2035). The availability and widespread clinical adoption of established pharmacologic therapies form a core demand driver for the North American osteoarthritis therapeutics market. NSAIDs, corticosteroids, and opioid analgesics remain integral to osteoarthritis treatment algorithms across early, moderate, and advanced disease stages. Their long-standing regulatory approval and inclusion in clinical guidelines support consistent prescribing across primary care, orthopedics, and pain management settings. As osteoarthritis is a chronic and progressive condition, patients often require sustained pharmacologic intervention over extended periods, reinforcing recurring demand. 

Asia-Pacific healthcare contract development and manufacturing organization (CDMO) market was valued at $170.5 billion in 2025 and is growing at a CAGR of 7.0% during the forecast period (2026-2035). The Asia-Pacific healthcare contract development and manufacturing organization (CDMO) market is gaining prominence as pharmaceutical and biotechnology companies increasingly leverage the region’s manufacturing capabilities and technical expertise. A combination of expanding healthcare demand, cost-efficient operations, and improving regulatory maturity is encouraging sponsors to partner with CDMOs across development and commercial manufacturing stages. Countries in the region are strengthening compliance frameworks and investing in modern facilities, which is enhancing confidence among global clients. The market is also benefiting from a growing pipeline of both innovative and established therapies requiring scalable outsourcing solutions. As a result, the Asia-Pacific is becoming an integral part of global pharmaceutical supply chains. This shift reflects the region’s transition from volume-driven manufacturing to value-added services.

Global virtual reality (VR) in the gaming market was valued at $31.7 billion in 2024 and is growing at a CAGR of 27.2% during the forecast period (2026-2035). Demand for portable immersive gaming experiences is rising as gamers prefer flexibility beyond fixed setups. Lightweight, wearable display solutions facilitate large-screen gaming anywhere, aligning with the mobile and hybrid gaming ecosystem trend, thereby driving market growth. Recent advancements in high-refresh, micro-display technologies have made it possible to deliver large virtual screens in compact, wearable formats, combining portability with premium visual performance. For instance, in January 2026, the ROG XREAL R1 gaming glasses offer a portable solution for gamers seeking a 171-inch virtual screen with a 240Hz refresh rate. It provides a lightweight display ideal for on-the-go gaming with devices like the ROG Xbox Ally, or as an additional monitor in cramped setups. Featuring the world's first 240Hz micro-OLED FHD technology, the glasses deliver vibrant visuals suitable for both AAA titles and competitive multiplayer games. With a 57° field of view, users experience a spacious virtual environment, akin to viewing a large screen from a distance, ensuring immersive gameplay and entertainment. The glasses also include a mode called Anchor Mode, allowing the virtual screen to stabilize for standard display usage.

US smart transportation market was valued at $2.15 billion in 2025 and is projected to reach $4.8 billion by 2035, growing at a CAGR of 8.6% during the forecast period (2026–2035). The acceleration of smart transportation in the US is increasingly driven by the deployment of Intelligent Transportation Systems (ITS) technologies across roadways and transit networks. Official data from the 2023 ITS Deployment Tracking Survey shows that transportation agencies are expanding the use of digital and connected systems that directly impact traffic management, traveler information, and fare payment operations nationwide. This systematic expansion is enhancing operational capabilities, improving commuter experience and safety, and laying the groundwork for broader multimodal integration across rail, road, and transit services. 

Global dental care equipment market was valued at $10.1 billion in 2025 and is growing at a CAGR of 5.8% during the forecast period (2026-2035). Rising adoption of digital dentistry solutions, particularly digital imaging, 3D scanning, and CAD/CAM technologies, is driving market growth for advanced dental equipment. This trend is reflected in the increasing emphasis on clinical education, research, and evidence-based practices within the dental industry. For instance, in September 2025, Align Technology, Inc. specializes in the design and manufacture of the Invisalign System, iTero intraoral scanners, and exocad CAD/CAM software, contributing to advancements in digital orthodontics and restorative dentistry. At its Global Faculty Meeting, over 100 trained doctor educators participated in extensive workshops on the latest innovations and clinical evidence related to Invisalign and iTero solutions. The event also highlighted the launch of a new clinical evidence webpage with 800+ peer-reviewed publications and an expanded Align Global Gallery showcasing over 1,500 case studies, alongside the announcement of more than $4 million in grants for orthodontic and dental research.

The UK smart transportation market stood at USD 0.55 billion in 2025 and is expected to grow to USD 1.05 billion by 2035, registering a compound annual growth rate of 6.6% from 2026 to 2035. The expansion of digital ticketing and integrated transport systems is a key driver shaping the UK’s smart transportation landscape. Government efforts to modernise fare collection, simplify access, and improve multimodal connectivity are influencing how people use services across rail, bus, and urban networks. This drive is closely tied to broader transport reform goals set out by the Department for Transport, which include improving public transport reliability and enabling seamless journey experiences for passengers. 

UK cloud database and DBaaS market was valued at $1.6 billion in 2025 and is projected to reach $7.3 billion by 2035, growing at a CAGR of 16.6% during the forecast period (2026–2035). The rapid uptake of cloud computing across UK businesses and public sector organisations is a major driver of growth for cloud database and database?as?a?service (DBaaS) offerings. As firms and institutions increasingly move core computing, storage and application workloads to cloud environments, demand for scalable, flexible and managed database services rises accordingly. Broad cloud adoption reduces barriers to deploying cloud databases, supports hybrid and multi?cloud strategies and enables organisations to modernise legacy systems.